Nkabyo, Yvonne S., Young-Mi Go, Thomas R. Ziegler, and Dean P. Jones. Extracellular cysteine/cystine redox regulates the p44/42 MAPK pathway by metalloproteinase-dependent epidermal growth factor receptor signaling. Am J Physiol Gastrointest Liver Physiol 289: G70 -G78, 2005. First published March 3, 2005 doi:10.1152/ajpgi.00280.2004.-Previous research shows that stimulation of proliferation of colon carcinoma (Caco-2) cells by a more reduced extracellular cysteine/cystine (Cys/CySS) redox state occurs with no apparent effect on intracellular glutathione and that this stimulation is lost on addition of epidermal growth factor. The purpose of the present study was to determine whether a more reduced extracellular Cys/CySS redox state activates the mitogenic p44/p42 mitogen-activated protein kinase (MAPK) pathway and whether this is signaled through the epidermal growth factor receptor (EGFR). Caco-2 cells were exposed to a range of physiological extracellular redox conditions from Ϫ150 to 0 mV. In the absence of added growth factors, the most reduced (Ϫ150 mV) redox state induced an 80% increase in EGFR phosphorylation, and this was followed by a marked increase in phosphorylation of p44/p42 MAPK. Inhibitors of EGFR (AG1478) and p44/p42 MAPK (U0126) phosphorylation blocked redox-dependent p44/p42 phosphorylation, indicating that signaling occurred by EGFR. These effects were inhibited by pretreatment with a nonpermeant alkylating agent, showing that signaling involved thiols accessible to the extracellular space. The EGFR ligand TGF-␣ was increased in culture medium at more reduced redox states. Redox-dependent phosphorylation of EGFR was completely prevented by a metalloproteinase inhibitor (GM6001), and an antibody to TGF-␣ partially inhibited the phosphorylation of p44/p42 MAPK by redox. Thus the data show that a redox-dependent activation of metalloproteinase can stimulate the mitogenic p44/p42 MAPK pathway by a TGF-␣-dependent mechanism. Because Cys availability and Cys/CySS redox are dependent on nutrition, disease, and environmental exposures, the results suggest that cell proliferation could be influenced physiologically by Cys-dependent redox effects on growth factor signaling pathways.
oxidation reduction; intestine; transforming growth factor-␣; glutathione ABUNDANT EVIDENCE DEMONSTRATES that reversible redox reactions of thiol/disulfide couples have important roles in the regulation of fundamental cellular processes such as cell proliferation, differentiation, and apoptosis (19, 27, 32) . Most of the available research on thiol/disulfide couples has focused on intracellular glutathione (GSH), the most abundant low molecular weight thiol in cells. However, recent evidence suggests that the extracellular thiol/disulfide redox environment may also be important. The predominant low molecular weight thiol/disulfide pool found in plasma consists of the cysteine (Cys)/cystine (CySS) couple (16) . The redox state (E h ) of plasma Cys/CySS differs considerably between individuals, from about Ϫ130 to Ϫ20 mV (16) , and is oxidized in association with aging (17) and smoking (26) . Oral intake of Cys results in a more reduced redox state (36) .
In vitro studies showed that bromodeoxyuridine (BrdU) incorporation in colon carcinoma (Caco-2) cells cultured at Ϫ150 mV was twice the rate at 0 mV and occurred without an associated change in intracellular GSH (15) . In Caco-2 cells that were allowed to undergo spontaneous differentiation, extracellular redox was more oxidized in differentiated, nondividing cells than in proliferative cells (27) . Other studies, focused on chemicals that determine Cys/CySS redox, i.e., Cys or CySS, have clearly demonstrated the involvement of Cys and/or CySS in cellular proliferation. For example, exogenous Cys was shown to promote proliferation in Caco-2 cells (29) and in intestinal lamina propria T-lymphocytes (35) without increasing intracellular GSH (29) . However, the mechanism by which Cys or reduced Cys/CySS redox conditions increase proliferation is not clear.
The intestine produces peptide growth factors that are important mediators of intestinal epithelial growth (8) . Several lines of evidence support the concept of thiol-mediated regulation of early mitogenic signaling events associated with the plasma membrane. For instance, increased kinase activity of the insulin and epidermal growth factor (EGF) receptors (EGFRs) was observed in the presence of sulfhydryl agents (6) . Also, reduction of disulfides influences receptor autophosphorylation and, consequently, phosphorylation of downstream substrates (10) . Similarly, GSH is required for growth stimulation by pancreatic spasmolytic peptide in Colo-357 cells (30) .
EGF and other EGF-like peptides stimulate proliferation in intestinal cells by binding to the EGFR (39) . Ligand binding results in receptor dimerization and activation of an intracellular tyrosine kinase domain. This results in both autophosphorylation and phosphorylation of various intracellular effector proteins, such as proteins of the mitogen-activated protein kinase (MAPK) pathway (25) . The EGFR has two cysteinerich extracellular domains, making it a candidate for sensitivity to extracellular thiol/disulfide redox.
Understanding thiol-dependent control is complicated by the presence of reactive oxygen species (ROS) signaling. Many extracellular stimuli, including EGF, induce the production of ROS in cells, which act as second messengers (22, 3) . Activation of downstream p44/p42 MAPK by ROS (5, 11, 18) has been shown to be mediated by Src (11, 41) , inhibition of protein tyrosine kinases (21) , and glutathiolation of Ras (1). However, ultraviolet light (UVA) and EGF, through overproduction of ROS, inhibited EGFR activation as well as p44/p42 MAPK; this was rescued by the antioxidant vitamin E (24) . These studies define intracellular effects of ROS but have not clarified the role of extracellular thiols and disulfides.
Ligands of the EGFR [EGF, transforming growth factor (TGF)-␣, heparin-bound EGF, amphiregullin, betacellulin, and epiregulin] are synthesized as transmembrane precursors that must be cleaved by metalloproteinases to release mature ligands (23) . The two closely related metalloproteinase families, matrix metalloproteinases and metalloprotease-distintegrins, both contain cysteine residues (38, 40) and are also redox sensitive (34, 37) . Thus, in addition to the possibility that thiol/disulfide redox could directly alter the EGFR, extracellular redox could affect the activity of metalloproteinases and thereby alter release of surface-bound EGFR ligands.
The aim of the present study was to determine whether changes in the extracellular Cys/CySS redox could affect signaling through the p44/p42 MAPK pathway signaled by EGFR. For this purpose, we utilized Caco-2 cells, a human colon carcinoma cell line in which cell proliferation rate changes in response to altered Cys/CySS redox (15) . Redox conditions of 0, Ϫ80, and Ϫ150 mV were used to treat the cells, and the phosphorylation of EGFR and p44/p42 MAPK was determined. Our results show a redox-dependent phosphorylation of the EGFR, with increased phosphorylation at more reducing conditions. This was followed by a significant increase in p44/p42 MAPK phosphorylation. Effects of inhibition of metalloproteinases and TGF-␣ release were also studied. The results show that the activation of this mitogenic pathway by extracellular redox involves metalloproteinases but does not exclude additional direct effects of extracellular thioldisulfide redox state on the EGFR.
MATERIALS AND METHODS

Chemicals.
Mouse anti-human phospho-EGFR antibody, phosphop44/p42 MAPK antibody, rabbit anti-human EGFR antibody, and p44/p42 antibody were purchased from Cell Signaling Technologies (Beverly, MA). Horseradish peroxidase-labeled goat anti-mouse and goat anti-rabbit IgG were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The matrix metalloproteinase inhibitor GM6001, the p44/p42 MAPK kinase inhibitor U0126, the TGF-␣ ELISA kit, and the Diphtheria toxin CRM mutant (CRM 197) were purchased from Calbiochem (San Diego, CA). The alkylating agents 4-acetamido-4Ј-maleimidylstilbene-2, 2Ј-disulfonic acid (AMS), and monobromotrimethyl-ammoniobimane bromide (qBBr) were purchased from Molecular Probes (Eugene, OR). Anti-TGF-␣ antibody was purchased from Oncogene (San Diego, CA). MEM and FBS were purchased from Life Technologies (Grand Island, NY). Chemiluminescence detection reagents were purchased from Amersham Pharmacia Biotech (Piscataway, NJ). Bio-Rad dye reagent was purchased from Bio-Rad laboratories (Richmond, CA). The cell proliferation ELISA kit was purchased from Roche Molecular Biochemicals (Indianapolis, IN). All other chemicals were purchased from Sigma (St. Louis, MO).
Cell culture. The human colon cancer cell line Caco-2 was obtained from the American Type Culture Collection (Rockville, MD). Cells were studied between passages 21 and 25. For all experiments, cells were cultured in MEM, supplemented with 2 mM glutamine, 10 g/ml streptomycin, 10 U/ml penicillin, and 10% fetal calf serum, at 37°C, 95% air-5% CO 2. Cells were plated at low density (8 ϫ 10 (7), were added to cyst(e)ine-free DMEM, containing 4 mM glutamine, 10 U/mL penicillin, and 10 g/ml streptomycin (12): E h ϭ Ϫ250 ϩ 30 log [(CySS)/(Cys) 2 ] for pH 7.4 in culture medium, where respective concentrations are expressed in molarity. For EGFR phosphorylation studies, cells were treated for 2, 5, 7, and 10 min. For MAPK phosphorylation studies, cells were treated with redox-controlled media for 5, 10, 15, and 30 min before harvest. Cells were seeded in 96-well plates at a density of 10 4 cells/well for measurement of 5-bromo-2-deoxyuridine incorporation into cellular DNA. For all other experiments, the Ϫ150-mV condition and the 5-min time point were used.
For collection of samples, medium was aspirated, cells were washed twice with PBS, and cells were lysed with 200 l of lysis buffer containing 50 mM HEPES, 150 mM NaCl, 0.1 mM PMSF, 1% Triton X-100, and 10% glycerol. These extracts were incubated for 20 min at 4°C and spun at 10,000 g for 10 min. The supernatant was collected, the concentration of protein was determined by the Bradford method (4) , and the samples were analyzed for EGFR and p44/p42 MAPK phosphorylation by Western blotting.
p44/p42 MAPK phosphorylation. Cell lysates were resolved by electrophoresis with a 7.5% resolving gel. Proteins were transferred onto nylon membranes (Amersham Pharmacia Biotech), and the membranes were blocked with 5% nonfat milk for 1 h. The membranes were incubated with primary phospho-p44/p42 MAPK antibody at 4°C overnight, incubated with horseradish peroxidaseconjugated anti-mouse secondary antibody for 1 h, and developed according to the chemiluminescence system. Densitometry was performed for quantification. The levels of total MAPK were used to ensure equal protein loading. The same membranes were stripped using a stripping buffer containing 62.5 mM Tris ⅐ HCl (pH 6.8), 2% SDS, and 100 mM ␤-mercaptoethanol. The stripped membranes were washed three times with PBS, blocked with nonfat dry milk for 1 h, and incubated with rabbit anti-MAPK overnight at 4°C. Membranes were then incubated with goat anti-rabbit secondary antibody for 1 h and developed according to the chemiluminescence system. EGFR phosphorylation. To determine whether the phosphorylation of the EGFR was responsible for the downstream phosphorylation of MAPK, cells were treated with the above Cys/CySS redox conditions for 2, 5, 7, and 10 min, which were time points earlier than the maximal phosphorylation of p44/p42 MAPK. Briefly, cellular protein was harvested as above and resolved by electrophoresis. Western blotting using an antibody specific for phospho-EGFR (Tyr1068) was used to determine the phosphorylation of the EGFR in response to the extracellular redox conditions. Densitometry was performed for quantification. Levels of total EGFR were used to control for protein loading. Membranes were stripped and reprobed with rabbit anti-EGFR at 4°C overnight, incubated with goat anti-rabbit secondary antibody for 1 h, and developed according to the chemiluminescence system.
Treatment with inhibitors/alkylating agents. Cells were pretreated for 30 min with either GM6001, anti-TGF-␣, or CRM197, or for 1 h with either AMS, qBBr, U0126, or AG1478, washed, and then harvested (zero-time controls) or treated with the Ϫ150-mV condition for 5 min. Controls were treated with the Ϫ150-mV condition alone. The cellular protein was collected, and the phosphorylation of p44/p42 MAPK as well as EGFR were determined as described.
BrdU incorporation. Cells were plated in 96-well plates for 24 h and then treated for 24 with DMEM under the Ϫ150-mV condition, without or with AG1478, GM6001, or U0126. To measure DNA synthesis, cells were incubated in the presence of 100 M BrdU for 2 h. After labeling, BrdU incorporation was measured by colorimetric immunoassay using a commercially available cell proliferation ELISA kit.
Statistical analysis. Where appropriate, tests for statistically significant differences (P Ͻ 0.05) were performed by ANOVA. Student's t-test was used to test for differences between treatment (plus inhibitor/alkylating agent) and control (Ϫ150 mV) conditions. Data are given as means Ϯ SE; P values of Ͻ0.05 were considered significant.
RESULTS
Effect of extracellular Cys/CySS redox on p44/p42 MAPK phosphorylation. Because our laboratory's previous studies showed that cell proliferation at Ϫ150 mV was greater than at Ϫ80 or 0 mV (15), we used these conditions to determine whether phosphorylation of the p44/p42 MAPK pathway was redox dependent. The results show that p44/p42 MAPK was phosphorylated by a more reduced extracellular redox in a time-dependent manner (Fig. 1, A and B) . At 10 min, there was a significant increase in phosphorylation of both p44 and p42 at Ϫ150 and Ϫ80 mV compared with 0 mV. To confirm the phosphorylation of p44/p42 MAPK by extracellular Cys/CySS redox, we investigated its inhibition by U0126, a specific inhibitor for MAPK kinase, which is upstream of p44/p42 MAPK in this signaling pathway (Fig.  1C) . The results show that the phosphorylation of p44/p42 MAPK by Cys/CySS redox was inhibited by pretreatment with U0126.
Phosphorylation of EGFR in response to extracellular Cys/ CySS redox. Changes in phosphorylation of the EGFR at Tyr1068 were measured as a function of Cys/CySS redox. Tyr 1068 is a direct binding site for Grb2/SH2 domain, which results in Ras activation and downstream activation of p44/p42 MAPK (31). The results (Fig. 2, A and B) showed that the most reduced Cys/CySS redox state (Ϫ150 mV) caused a significant increase in phosphorylation of the EGFR, which was maximal at 5 min. A similar pattern of phosphorylation with time was seen at Ϫ80 mV, and this was maximal at 5 min.
An inhibitor of EGFR phosphorylation, AG1478, was used to confirm that redox-dependent phosphorylation of EGFR was upstream of p44/p42 MAPK phosphorylation (Fig. 2C) under the same conditions. Cells were incubated at Ϫ150 mV without or with AG1478 and analyzed after 5 min. The results show that AG1478 inhibited EGFR phosphorylation at Tyr 1068 and that this inhibition of EGFR phosphorylation was associated with a dramatic inhibition of p44/p42 MAPK phosphorylation (Fig. 3) . Thus the results establish that, under these redox conditions, EGFR phosphorylation was upstream of MAPK phosphorylation.
Involvement of extracellular thiols. To determine whether the phosphorylation of EGFR and the subsequent downstream phosphorylation of MAPK induced by reducing extracellular redox conditions was dependent on extracellular thiols, we used the nonpermeant alkylating agents qBBr and AMS. The results show that treatment with the negatively charged alkylating agent AMS significantly attenuated both EGFR phosphorylation (Fig. 4A) as well as its downstream phosphorylation of MAPK (Fig. 4B) . In contrast, the positively charged qBBr had no significant effect. The AMS results suggest that the effect of extracellular Cys/CySS redox on the EGFR-MAPK pathway involves interaction of extracellular thiols. This conclusion is consistent with the previous finding that extracellular Cys/CySS affected cell proliferation without altering cellular GSH concentration (15) .
Metalloproteinases are involved in Cys/CySS redox phosphorylation of EGFR and p44/p42 MAPK by Cys/CySS redox.
Metalloproteinase action is required for ectodomain shedding of cellular EGFR ligands, which can activate the EGFR and p44/p42 MAPK signaling. To determine whether phosphorylation of EGFR by Cys/CySS redox involved metalloproteinases and subsequent release of membrane-bound EGFR ligands into cell medium, we used the general metalloproteinase inhibitor GM6001. Results (Fig. 5A) showed a significant inhibition of EGFR phosphorylation. General inhibition of metalloproteinases also significantly attenuated the phosphorylation of p44/p42 MAPK (Fig. 5B) . Thus one mechanism for extra- Fig. 1 . Extracellular cysteine (Cys)/cystine (CySS) redox activates p44/p42 mitogen-activated protein kinase (MAPK) phosphorylation. A: Caco-2 cells were exposed to 0-, Ϫ80-, and Ϫ150-mV conditions in culture medium for 5, 10, 15, and 30 min. Cellular protein was resolved by SDS-PAGE followed by Western blotting, as outlined in MATERIALS AND METHODS. Anti-phospho-p44/ p42 MAPK was used to detect activated MAPK, and anti-p44/p42 MAPK was used to control for protein loading. Blots shown are representative (and were run on the same gel but cut for better presentation) of 3 different experiments. B: densitometric analysis of MAPK phosphorylation in response to Cys/CySS redox. Results are expressed as percent of zero time p44/p42 MAPK phosphorylation. C: inhibition of MAPK phosphorylation by U0126. Cells were preincubated for 1 h with 10 M U0126, after which they were treated for 2, 5, 7, and 10 min with the Ϫ150-mV condition. Cells exposed to the Ϫ150-mV condition were used as the control group; zero time indicates cells not treated with either condition. Significant difference (P Ͻ 0.01): *Ϫ150 mV and Ϫ80 mV vs. 0 mV; # Ϫ150 mV vs. Ϫ80 mV.
cellular Cys/CySS redox-dependent phosphorylation of EGFR and p44/p42 MAPK involves activation of one or more metalloproteinases.
TGF-␣ is involved in the phosphorylation of p44/p42 MAPK by Cys/CySS redox.
The metalloproteinase inhibitor (GM6001) used also inhibits TGF-␣ release, and TGF-␣ is an EGFR ligand released by ectodomain shedding. Thus we evaluated the role of TGF-␣ release in redox signaling in Caco-2 cells by using a TGF-␣ antibody that blocks TGF-␣ activity. The results (Fig. 6A) show that blocking TGF-␣ with anti-TGF-␣ led to partial inhibition of the redox-dependent phosphorylation of p44/p42 MAPK. In contrast, CRM 197 , an inhibitor of the EGFR ligand heparin-bound EGF, had no effect on p44/ p42 MAPK activation (Fig. 6B) . Measurement of TGF-␣ in the culture medium by ELISA showed a significant increase in the amount of TGF-␣ released into culture medium at the more reduced Cys/CySS redox states (Fig. 6C) . Thus Cys/CySS redox regulates metalloproteinase action to release EGFR ligand(s), and release of TGF-␣ is at least partially responsible for redox-signaled phosphorylation of the p44/p42 MAPK pathway.
BrdU incorporation into cellular DNA. Because EGFR and p44/p42 MAPK phosphorylation leads to their activation and signaling in cell proliferation, we investigated the effect of inhibiting EGFR and p44/p42 MAPK phosphorylation on BrdU incorporation induced by Cys/CySS redox. The results (Fig. 7) show significant inhibition of BrdU incorporation on treatment with the metalloproteinase inhibitor GM6001, the EGFR inhibitor AG1478, and the MAPK kinase inhibitor U0126. These data show that one of the mechanisms by which extracellular Cys/CySS redox controls cell proliferation is # Ϫ150 mV vs. Ϫ80 mV. C: cells were cultured as previously described. Before harvesting, some cells were preincubated with 10 M AG1478 for 1 h. All cells were then exposed to the Ϫ150-mV condition for 5 min. Cellular protein was resolved on SDS-PAGE and immunoblotted for the phosphorylation of EGFR. Zero time indicates cells harvested after serum starvation. Control cells were exposed only to the Ϫ150-mV condition, and the treatment group was pretreated for 1 h with AG1478. Blots shown are representative of 3 different experiments. Densitometric analyses of Western blots in C. Results are expressed as percent of zero time. *After ANOVA, post hoc comparison showed that AG1478 significantly inhibited phosphorylation at Ϫ150 mV. through the phosphorylation of the EGFR resulting in the downstream phosphorylation of p44/p42 MAPK in a metalloproteinase-dependent manner.
DISCUSSION
The present data add to the understanding of redox signaling in growth control, which now appears to include at least three different redox-dependent processes. One of these involves cellular GSH, which must be maintained at high concentrations with a reduced GSH/GSSG redox state for rapid proliferation (12-14, 28, 33, 42) . The second involves ROS, which are generated during growth signaling by receptor tyrosine kinases, apparently mediated by mitogenic NADPH oxidases (9, 20) . A third involves Cys but, unlike the other two processes, appears to be extracellular and mediated by the redox state of the Cys/CySS pool (15, 27) . Cys is a precursor of GSH, and Cys or CySS can independently affect cell proliferation by altering the available Cys ϩ CySS pool. Consequently, experiments were performed with variation in Cys/CySS redox state under conditions where the total Cys ϩ CySS pool size was maintained constant. Under these conditions, varying extracellular Cys/CySS redox did not alter the concentration of cellular GSH or redox state of cellular GSH/GSSG (15) . Thus the results indicated that the growth stimulation due to extracellular Cys/CySS was not due to effects on cellular GSH. The present data support this interpretation by providing evidence that the response is blocked by a nonpermeant alkylating agent. Various growth factor receptors are sensitive to thiol content (5, 9) and redox (11) . We therefore hypothesized that Cys/CySS redox could affect the mitogenic signaling pathway via an extracellular effect on a receptor tyrosine kinase. The variation of extracellular Cys/ CySS redox did not alter the intracellular milieu maintained by the GSH/GSSG redox state (15) . To determine whether signaling occurred on the basal or apical surface, we used transwell plates to grow Caco-2 cells, treated them with the different redox conditions, and looked at EGFR and p44/p42 MAPK phosphorylation. In cells with a resistance of Ն200 ⍀/cm 2 , indicating the presence of tight junctions, there was very little EGFR or p44/p42 phosphorylation and there was no significant difference in extent of phosphorylation between Ϫ150 and 0 mV. Subconfluent and confluent cells differ in the integrity of the epithelial barrier and the rate of cell proliferation. Thus the data could indicate that the extracellular Cys/CySS redox state is important only under conditions where the barrier function is compromised. Alternatively, p44/p42 MAPK activity dramatically decreases in postconfluent cells (2) , and this decrease in activity could limit the ability to detect changes. Thus the results observed in the present study may not apply to normal tissue but rather be of importance only under conditions of epithelial injury or regeneration. The present data show that changes in extracellular Cys/ CySS redox affect phosphorylation of p44/p42 MAPK by an upstream effect on EGFR phosphorylation. In principle, this could occur by a direct effect involving Cys residues on the extracellular surface of EGFR or by an indirect effect on other systems that activate EGFR. The extracellular domain of the EGFR contains 51 Cys residues (39), making it a good candidate for thiol redox sensitivity. Moreover, EGFR does not require ligand binding for tyrosine kinase activity and dimerization (20) , and numerous studies have demonstrated the transactivation of EGFR by nonligands. However, because of the complexity of the system, we were unable to evaluate this direct effect. In contrast, the use of a general metalloproteinase inhibitor demonstrated the involvement of metalloproteinase. Metalloproteinases contain critical cysteine residues and have been shown to be redox sensitive (35, 38) . Thus the results provide evidence for an indirect mechanism for redox sensitivity but do not exclude direct effects.
A proposed scheme representing the sensitivity of the EGFR signaling pathway to extracellular Cys/CySS redox is given in Fig. 8 . The nearly complete inhibition by GM6001 indicates that a metalloproteinase could represent the major redoxsensitive event. However, because GM6001 inhibits multiple metalloproteinases, this experiment does not define the specific redox sensor, and additional research will be needed to identify the redox-sensitive protease. The EGFR inhibitor AG1478, as well as the MAPK kinase inhibitor U0126, completely blocked p44/p42 MAPK phosphorylation. These inhibitors, as well as GM6001, also dramatically inhibited cell proliferation measured by BrdU incorporation into cellular DNA. Extracellular redox control of cell proliferation by this pathway could have important influences on tissue homeostasis. The Cys/CySS redox varies from Ϫ20 to Ϫ130 mV in humans, with most reduced values found in young, healthy individuals (17) . Cys/ CySS redox is oxidized in smokers (26) and is reduced after an oral load of Cys (36) . Cys/CySS redox may be sufficient to contribute to variation in cell proliferation and thereby affect critical processes of tissue repair and maintenance under different pathophysiological conditions. In summary, these studies in human gut epithelial cells are the first to demonstrate that alteration of the extracellular Cys/CySS redox is sufficient to alter phosphorylation of p44/p42 MAPK, with the greatest phosphorylation observed at the most reducing conditions (Ϫ150 mV). The data show that EGFR is phosphorylated under these conditions and that Fig. 7 . The effect of inhibitors of metalloproteinases, EGFR, and MAPK kinase on BrdU incorporation. Cells were cultured as described and treated for 24 h with Ϫ150 mV alone or with Ϫ150 mV plus either GM6001 (5 M), AG1478 (10 M), or U0126 (10 M). BrdU incorporation into cellular DNA was measured as described. *Significant difference for Ϫ150 mV plus inhibitors vs. Ϫ150 mV alone (P Ͻ 0.01). Fig. 8 . Proposed scheme for redox signaling in growth stimulation by extracellular Cys/ CySS redox. The Cys/CySS couple is the major extracellular thiol pool and is therefore likely to be the main pool involved in extracellular redox signaling. Although cellular GSH and reactive oxygen species function in growth signaling, accumulating evidence indicates that additional extracellular redox-dependent steps are involved. These could include direct interaction with the redoxsensitive extracellular thiols of the growth factor receptor EGFR or by altering signaling interaction through thiols of other proteins such as metalloproteinases. The present data show that redox-sensitive cell proliferation in Caco-2 cells is dependent on metalloproteinases. Metalloproteinases cleave and release membrane-bound EGFR ligands such as TGF-␣, thereby stimulating EGFR phosphorylation. Phosphorylation of the EGFR leads to phosphorylation of p44/p42 MAPK downstream, which signals cell proliferation. Sites of inhibition by GM6001, AG1478, and U0126 are indicated. such phosphorylation signals MAPK phosphorylation. The data also demonstrate that this redox sensitivity involves extracellular thiols and metalloproteinase activation, with at least partial signaling through TGF-␣. These studies therefore indicate that extracellular Cys/CySS redox can signal cellular proliferation through the mitogenic MAPK pathway. Due to the existence of multiple metalloproteinases and signaling ligands, further studies are needed to determine which metalloproteinases and EGFR ligands are involved in EGFR phosphorylation as well as which Cys residues of the metalloproteinases or EGFR are responsive to Cys/CySS redox.
